Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis and Management of Parkinson's Disease.
Tarakad A, Jankovic J. Tarakad A, et al. Semin Neurol. 2017 Apr;37(2):118-126. doi: 10.1055/s-0037-1601888. Epub 2017 May 16. Semin Neurol. 2017. PMID: 28511252 Review.
Anosmia and Ageusia in Parkinson's Disease.
Tarakad A, Jankovic J. Tarakad A, et al. Int Rev Neurobiol. 2017;133:541-556. doi: 10.1016/bs.irn.2017.05.028. Epub 2017 Jun 27. Int Rev Neurobiol. 2017. PMID: 28802932 Review.
Strategies to mitigate impacts of the COVID-19 pandemic on patients treated with deep brain stimulation.
Kostick K, Storch EA, Zuk P, Blumenthal-Barby JS, Torgerson L, Yoshor D, Sheth S, Viswanathan A, Tarakad A, Jimenez-Shahed J, Goodman W, Lázaro-Muñoz G. Kostick K, et al. Among authors: tarakad a. Brain Stimul. 2020 Nov-Dec;13(6):1642-1643. doi: 10.1016/j.brs.2020.09.023. Epub 2020 Oct 2. Brain Stimul. 2020. PMID: 33017673 Free PMC article. No abstract available.
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.
Hill EJ, Mangleburg CG, Alfradique-Dunham I, Ripperger B, Stillwell A, Saade H, Rao S, Fagbongbe O, von Coelln R, Tarakad A, Hunter C, Dawe RJ, Jankovic J, Shulman LM, Buchman AS, Shulman JM. Hill EJ, et al. Among authors: tarakad a. Parkinsonism Relat Disord. 2021 Mar;84:105-111. doi: 10.1016/j.parkreldis.2021.02.006. Epub 2021 Feb 10. Parkinsonism Relat Disord. 2021. PMID: 33607526 Free PMC article.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
30 results